Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox dose-finding study in overweight or obese adults with type 2 diabetes
ACTRN12616000330448Phase 2Withdrawn
- Sponsor
- Westmead Hospital
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of deferasirox in type 2 diabetes mellitus (T2DM), sponsored by Westmead Hospital. Primary endpoints: Safety assessment and Change in BMI. Planned start Jun 2016; status: withdrawn.
02
Drugs
deferasirox
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12616000330448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000330448.